文献速递心血管MR

心脏磁共振时间-容积参数评估肥厚型心肌病舒张与收缩功能障碍的时间模式

Temporal patterns of diastolic and systolic dysfunction in hypertrophic cardiomyopathy assessed by cardiac magnetic resonance (CMR) time-volume parameters.
PubMed 文献 · Clin Radiol · 2025-11-12

研究纳入54例肥厚型心肌病患者与65例匹配对照,用 cine-CMR 时间-容积指标、左房容积指数(LAVI)及 PC-MRI 主动脉血流分析对照超声心动图分期。70%患者存在舒张功能障碍;LAVI 与 TPV/ET 比值鉴别舒张功能障碍的 AUC 均为0.85,NT-proBNP 与舒张功能障碍严重程度及 PFRE 相关(r=0.42,P=0.01),重复性 ICC 0.92–0.95。

要点

  • HCM 患者 PFR 286.4 vs 对照 397.8 ml/s,PFRA 0.91 vs 1.48 ml/s²,PFRE 321.3 vs 205.7 ms,LAVI 48.3 vs 29.8 ml/m²(均 P<0.001)。
  • LAVI 与 TPV-to-ET 比值鉴别舒张功能障碍的 AUC 均为0.85,优于单独时间-容积指标。
  • 梗阻性 HCM 的 TPV-to-ET 比值 0.55 vs 0.67,提示收缩加速延迟。

核心结论

  • 整合时间-容积指标、LAVI 与主动脉血流动力学的 CMR 框架可实现舒张功能障碍的准确分类、早期收缩功能不全的检出及梗阻相关血流动力学特征的描述,支持临床应用与纵向监测。

研究设计与样本

  • 研究纳入54例 HCM 患者与65例匹配对照,行 cine-CMR 获得 PFR、PFRA、PFRE、PER,于窦管交界行 PC-MRI 获得峰值流速、ET、TPV 及 TPV-to-ET 比值,并以 ASE/EACVI 基于 E/A 的标准作为舒张功能障碍分类参考。

关键影像表现/征象

  • HCM 患者 PFR 286.4 ml/s vs 对照 397.8 ml/s,PFRA 0.91 ml/s² vs 1.48 ml/s²,PFRE 321.3 ms vs 205.7 ms,LAVI 48.3 ml/m² vs 29.8 ml/m²(均 P<0.001)。
  • 梗阻性 HCM 的 TPV-to-ET 比值为0.55 vs 0.67,提示收缩加速延迟。
  • PER 下降提示尽管射血分数保留,仍存在亚临床收缩功能受损。

诊断标准与关键数值

  • HCM 患者中70%存在舒张功能障碍,按 ASE/EACVI 基于 E/A 的标准分类。
  • LAVI 与 TPV-to-ET 比值鉴别舒张功能障碍的 AUC 均为0.85,优于单独时间-容积指标。
  • 重复性 ICC 为0.92–0.95。

临床应用与阅片要点

  • LAVI 与 TPV-to-ET 比值鉴别舒张功能障碍的 AUC 均为0.85,可结合时间-容积指标用于 HCM 舒张功能障碍评估。
  • NT-proBNP 与舒张功能障碍严重程度及 PFRE 相关(r=0.42,P=0.01)。
  • PER 下降可提示射血分数保留时的亚临床收缩功能受损。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Diastolic dysfunction (DD) is central to hypertrophic cardiomyopathy (HCM), yet comprehensive cardiac magnetic resonance (CMR)-based staging is limited. We evaluated a multiparametric CMR framework combining time-volume indices, left atrial volume index (LAVI), and phase-contrast magnetic resonance imaging (PC-MRI) flow analysis against echocardiographic staging and healthy controls.

MATERIALS AND METHODS: Fifty-four HCM patients and 65 matched controls underwent cine-CMR to derive peak filling rate (PFR), peak filling rate acceleration (PFRA), peak filling rate end time (PFRE), and peak ejection rate (PER). PC-MRI at the sinotubular junction yielded peak velocity, ejection time (ET), time to peak velocity (TPV), and TPV-to-ET ratio. LAVI was measured from 4-chamber cine. Serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) and troponin I were analysed. DD was classified per American Society of Echocardiography / European Association of Cardiovascular Imaging (ASE/EACVI) early-to-late diastolic mitral inflow velocity ratio (E/A)-based criteria. Diagnostic performance was assessed by receiver operating characteristic (ROC) analysis; reproducibility was assessed by intraclass correlation coefficients (ICCs).

RESULTS: DD was present in 70% of HCM patients. In controls, HCM showed a lower PFR (286.4 vs 397.8 ml/s), reduced PFRA (0.91 vs 1.48 ml/s2), prolonged PFRE (321.3 vs 205.7 ms), and higher LAVI (48.3 vs 29.8 ml/m2) (all P<0.001). Obstructive HCM demonstrated delayed systolic acceleration with a lower TPV-to-ET ratio (0.55 vs 0.67). LAVI and TPV-to-ET ratio each achieved an area under the curve (AUC) of 0.85 for DD discrimination, exceeding isolated time-volume indices. NT-proBNP correlated with DD severity and PFRE (r=0.42, P=0.01). PER decline indicated subclinical systolic impairment despite preserved ejection fraction (EF). Reproducibility was excellent (ICC: 0.92-0.95).

CONCLUSION: A CMR framework integrating time-volume metrics, LAVI, and aortic flow kinetics enables accurate DD classification, detection of early systolic dysfunction, and characterisation of obstruction-related haemodynamics in HCM, supporting clinical application and longitudinal surveillance.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Dereli Bulut SS, Akcayoz B, Sakci Z, et al. Temporal patterns of diastolic and systolic dysfunction in hypertrophic cardiomyopathy assessed by cardiac magnetic resonance (CMR) time-volume parameters. Clin Radiol. 2025. PMID: 41380646. doi:10.1016/j.crad.2025.107176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。